---
title: "Asthma and Vitamin D Receptor - many pages"
slug: "asthma-and-vitamin-d-receptor-many-pages"
aliases:
  - "/Asthma+and+Vitamin+D+Receptor+-+many+pages"
  - "/15805"
tiki_page_id: 15805
date: 2025-02-04
---


{{< toc >}}

---

#### Asthmatics with a poor Vitamin D Receptor were 4 X more likely to have exacerbation in 1 year - Jan 2025

 **Vitamin D Receptor rs2228570 Gene Polymorphism Is Associated with Asthma Severity and Exacerbations** 

Sekiko Uehara, Keita Hirai  , Toshihiro Shirai, Hinako Otaki, Taisuke Akamatsu, Kunihiko Itoh 

Biological and Pharmaceutical Bulletin 2025 Volume 48 Issue 1 Pages 86-92 DOI https://doi.org/10.1248/bpb.b24-00684

<img src="https://d1bk1kqxc0sym.cloudfront.net/attachments/webp/asthma-vdr-table.webp" alt="image" width="700">

Vitamin D plays a crucial role in immune system function. Several studies have indicated that genetic variations in the vitamin D receptor (VDR) and vitamin D binding protein (VDBP, encoded by GC gene) increase the risk of developing asthma. However, the effect of these variations on the prognosis and clinical outcomes of asthma remains unclear. This study, involving 152 adult patients with asthma, aimed to assess the influence of VDR and GC polymorphisms on asthma severity and its exacerbation. Gene polymorphisms previously associated with asthma risk were analyzed, and VDR mRNA expression levels were evaluated in peripheral blood mononuclear cells. 

The AA genotype of the VDR rs2228570 polymorphism was associated with an 

*  **elevated risk of severe asthma**  compared to the AG/GG genotype ( **odds ratio, 3.20** ; 95% confidence interval <span>[CI]</span>, 1.24–8.28). 

Furthermore, patients with the rs2228570 AA genotype showed an 

*  **elevated risk of exacerbation**  during the 1-year follow-up period ( **hazard ratio, 4.01** ; 95% CI, 1.75–9.15). 

VDR mRNA expression was significantly reduced in patients with the AA genotype. Furthermore, the mRNA expression levels of GLCCI1, HDAC2, NR3C1, and NFE2L2, which are associated with steroid response, were reduced in patients with the AA genotype. 

Our findings indicate that patients with the AA genotype of VDR rs2228570 are more likely to experience severe asthma and exacerbations. This polymorphism has the potential to reduce vitamin D efficacy by altering VDR function and expression, potentially resulting in increased inflammation and reduced steroid responsiveness in patients with asthma.

 **<i class="fas fa-file-pdf" style="margin-right: 0.3em;"></i><a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/asthma-vdr-compresspdf.pdf">Download the PDF from VitaminDWiki </a>** 

---

#### Best VDR Activators for prevent/treat Asthma: Resveratrol, Quercetin, Curcumin - Feb 2025

 **Asked  [Perplexity AI - Deep Research](https://www.perplexity.ai/search/the-many-supplements-that-acti-WA7q8c_xTLa8uNrCprZL5Q)** 

 **The many supplements that activate the Vitamin D Receptor include Magnesium, Omega-3, Resveratrol, Quercetin , Zinc, Boron, ginger, curcumin, Progesterone, Sulfroaphane, Butyrate, and Berberine. Is there any hint as to which one is best for Asthma?** 

 **<span style="color:#F69;">The Role of Vitamin D Receptor-Activating Supplements in Asthma Management: A Comprehensive Analysis</span>** 

 **<span style="color:#00F;">Summary of Key Findings</span>** 

Emerging research highlights the potential of various dietary supplements to modulate asthma pathophysiology through activation of the Vitamin D Receptor (VDR). Among the supplements investigated—Magnesium, Omega-3, Resveratrol, Quercetin, Zinc, Boron, Ginger, Curcumin, Progesterone, Sulforaphane, Butyrate, and Berberine

—three compounds stand out for their robust evidence in asthma models:  **Resveratrol** ,  **Quercetin** , and  **Curcumin** . 

These agents demonstrate synergistic effects with Vitamin D, reduce airway inflammation, and improve clinical outcomes in preclinical and clinical studies.

 **<span style="color:#00F;">Mechanisms of VDR Activation and Asthma Pathophysiology</span>** 

The VDR plays a pivotal role in immune regulation and airway homeostasis. Polymorphisms in the VDR gene are associated with increased asthma susceptibility, highlighting its importance in disease modulation [5](https://pubmed.ncbi.nlm.nih.gov/15282199/) [14](https://www.spandidos-publications.com/10.3892/etm.2018.6867). Vitamin D itself enhances steroid responsiveness by upregulating glucocorticoid receptors (GR-α) and suppressing pro-inflammatory cytokines like IL-17F and IL-4 [7](https://onlinelibrary.wiley.com/doi/10.1155/2021/9947370) [22](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0111599). Supplements that potentiate VDR signaling may amplify these benefits, particularly in patients with Vitamin D deficiency or steroid resistance.

 **<span style="color:#00F;">Comparative Analysis of Key Supplements</span>** 

 **1) Resveratrol** 

Resveratrol, a polyphenol found in grapes and berries, demonstrates multifaceted anti-asthmatic effects:

*  **Anti-Inflammatory Action** : Reduces eosinophil infiltration, Th2 cytokines (IL-4, IL-5, IL-13), and TGF-β1-driven epithelial-mesenchymal transition (EMT), a key process in airway remodeling [9](https://pmc.ncbi.nlm.nih.gov/articles/PMC5102830/) [10](https://pmc.ncbi.nlm.nih.gov/articles/PMC6306424/).

*  **Synergy with Vitamin D** : Enhances VDR-RXR heterodimerization and potentiates 1,25D binding to VDR, amplifying anti-inflammatory effects [11](https://pubmed.ncbi.nlm.nih.gov/25536521/).

*  **Clinical Relevance** : Suppresses airway hyperresponsiveness (AHR) and inflammation in murine models, with efficacy comparable to corticosteroids but with fewer side effects [10](https://pmc.ncbi.nlm.nih.gov/articles/PMC6306424/) [12](https://pmc.ncbi.nlm.nih.gov/articles/PMC7870687/).

 **2) Quercetin** 

Quercetin, a flavonoid abundant in fruits and vegetables, exhibits rapid bronchodilatory and immunomodulatory effects:

*  **Bronchodilation** : Inhibits phosphodiesterase-4 (PDE4), increasing cAMP levels and relaxing airway smooth muscle [17](https://pmc.ncbi.nlm.nih.gov/articles/PMC3763034/) [18](https://pmc.ncbi.nlm.nih.gov/articles/PMC7227109/).

*  **Immune Regulation** : Shifts Th1/Th2 balance by suppressing GATA-3 (Th2 transcription factor) and enhancing T-bet (Th1 promoter), reducing IgE and eosinophil levels [18](https://pmc.ncbi.nlm.nih.gov/articles/PMC7227109/) [20](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725497/).

*  **Oxidative Stress Mitigation** : Activates Nrf2/HO-1 pathways, reducing lipid peroxidation and enhancing antioxidant defenses [19](https://www.spandidos-publications.com/10.3892/mmr.2016.5563).

 **3) Curcumin** 

Curcumin, the active compound in turmeric, modulates critical inflammatory pathways:

*  **PPARγ Activation** : Suppresses NF-κB-driven inflammation and mucus hypersecretion in ovalbumin (OVA)-induced asthma models [4](https://pmc.ncbi.nlm.nih.gov/articles/PMC6470457/).

*  **Airway Remodeling** : Attenuates subepithelial fibrosis and collagen deposition by inhibiting TGF-β/Smad signaling [19](https://www.spandidos-publications.com/10.3892/mmr.2016.5563).

*  **Clinical Trials** : Reduces exacerbations and improves lung function in combination with standard therapies, though direct VDR interactions require further study [4](https://pmc.ncbi.nlm.nih.gov/articles/PMC6470457/).

 **<span style="color:#00F;">Supporting Evidence for Other Supplements</span>** 

*  **Magnesium** : While serum magnesium levels correlate with asthma severity, its role is primarily as a bronchodilator rather than a direct VDR activator [3](https://journals.lww.com/ecdt/fulltext/2019/68040/serum_levels_of_vitamin_d,_magnesium,_and_calcium.12.aspx).

*  **Berberine** : Limited evidence in asthma; focuses on metabolic and antimicrobial benefits [21](https://www.buzzrx.com/blog/what-are-berberine-benefits-and-drawbacks).

*  **Zinc, Omega-3, Sulforaphane** : Absent from the provided studies in an asthma context, though theoretical immune benefits exist.

 **<span style="color:#00F;">Conclusion: Prioritizing Supplements for Asthma Management</span>** 

Based on current evidence:

1.  **Resveratrol**  emerges as the most promising due to its dual anti-inflammatory and VDR-synergistic effects, particularly in steroid-resistant asthma.

1.  **Quercetin**  offers acute symptom relief and long-term immune modulation, making it ideal for exacerbation management.

1.  **Curcumin**  provides robust anti-remodeling effects, though further research is needed to clarify its VDR-specific mechanisms.

 **Clinical Implications** : Combining these supplements with Vitamin D supplementation may optimize outcomes, especially in deficient populations. Future trials should explore dose-response relationships and synergistic formulations.

 **<span style="color:#00F;">Future Directions</span>** 

*  **Personalized Medicine** : Genetic screening for VDR polymorphisms could identify patients most likely to benefit from supplementation [5](https://pubmed.ncbi.nlm.nih.gov/15282199/) [14](https://www.spandidos-publications.com/10.3892/etm.2018.6867).

*  **Combination Therapies** : Investigating Resveratrol + Vitamin D or Quercetin + corticosteroids may enhance efficacy while minimizing steroid doses.

*  **Long-Term Safety** : Despite promising data, prolonged use of high-dose supplements requires rigorous safety assessments.

This analysis underscores the potential of natural compounds to complement conventional asthma therapies, offering a paradigm shift toward integrative

---

#### A poor VDR increases the risk of Asthma (but not the opposite assocation) - Feb 2025

What is the direction of the association between the Vitamin D receptor and Asthma? Does a poor VDR increase the risk of Asthma or does Asthma reduce the activation of the VDR?

 **[Perplexity Deep Research](https://www.perplexity.ai/search/what-is-the-direction-of-the-a-lmopy0OJROykvQnaEtYE5Q)** 

* [Parkinson's Disease might be treated by TENS](/posts/parkinsons-disease-might-be-treated-by-tens)



<pre style="background-color: #e0e0e0; white-space: pre-wrap;">
<code class="language-text">
Markdown:
--------
{{&lt; toc &gt;}}

---

#### Asthmatics with a poor Vitamin D Receptor were 4 X more likely to have exacerbation in 1 year - Jan 2025

 **Vitamin D Receptor rs2228570 Gene Polymorphism Is Associated with Asthma Severity and Exacerbations** 

Sekiko Uehara, Keita Hirai  , Toshihiro Shirai, Hinako Otaki, Taisuke Akamatsu, Kunihiko Itoh 

Biological and Pharmaceutical Bulletin 2025 Volume 48 Issue 1 Pages 86-92 DOI https://doi.org/10.1248/bpb.b24-00684

&lt;img src=&quot;https://d1bk1kqxc0sym.cloudfront.net/attachments/webp/asthma-vdr-table.webp&quot; alt=&quot;image&quot; width=&quot;700&quot;&gt;

Vitamin D plays a crucial role in immune system function. Several studies have indicated that genetic variations in the vitamin D receptor (VDR) and vitamin D binding protein (VDBP, encoded by GC gene) increase the risk of developing asthma. However, the effect of these variations on the prognosis and clinical outcomes of asthma remains unclear. This study, involving 152 adult patients with asthma, aimed to assess the influence of VDR and GC polymorphisms on asthma severity and its exacerbation. Gene polymorphisms previously associated with asthma risk were analyzed, and VDR mRNA expression levels were evaluated in peripheral blood mononuclear cells. 

The AA genotype of the VDR rs2228570 polymorphism was associated with an 

*  **elevated risk of severe asthma**  compared to the AG/GG genotype ( **odds ratio, 3.20** ; 95% confidence interval &lt;span&gt;[CI]&lt;/span&gt;, 1.24–8.28). 

Furthermore, patients with the rs2228570 AA genotype showed an 

*  **elevated risk of exacerbation**  during the 1-year follow-up period ( **hazard ratio, 4.01** ; 95% CI, 1.75–9.15). 

VDR mRNA expression was significantly reduced in patients with the AA genotype. Furthermore, the mRNA expression levels of GLCCI1, HDAC2, NR3C1, and NFE2L2, which are associated with steroid response, were reduced in patients with the AA genotype. 

Our findings indicate that patients with the AA genotype of VDR rs2228570 are more likely to experience severe asthma and exacerbations. This polymorphism has the potential to reduce vitamin D efficacy by altering VDR function and expression, potentially resulting in increased inflammation and reduced steroid responsiveness in patients with asthma.

 **&lt;i class=&quot;fas fa-file-pdf&quot; style=&quot;margin-right: 0.3em;&quot;&gt;&lt;/i&gt;&lt;a href=&quot;https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/asthma-vdr-compresspdf.pdf&quot;&gt;Download the PDF from VitaminDWiki &lt;/a&gt;** 

---

#### Best VDR Activators for prevent/treat Asthma: Resveratrol, Quercetin, Curcumin - Feb 2025

 **Asked  [Perplexity AI - Deep Research](https://www.perplexity.ai/search/the-many-supplements-that-acti-WA7q8c_xTLa8uNrCprZL5Q)** 

 **The many supplements that activate the Vitamin D Receptor include Magnesium, Omega-3, Resveratrol, Quercetin , Zinc, Boron, ginger, curcumin, Progesterone, Sulfroaphane, Butyrate, and Berberine. Is there any hint as to which one is best for Asthma?** 

 **&lt;span style=&quot;color:#F69;&quot;&gt;The Role of Vitamin D Receptor-Activating Supplements in Asthma Management: A Comprehensive Analysis&lt;/span&gt;** 

 **&lt;span style=&quot;color:#00F;&quot;&gt;Summary of Key Findings&lt;/span&gt;** 

Emerging research highlights the potential of various dietary supplements to modulate asthma pathophysiology through activation of the Vitamin D Receptor (VDR). Among the supplements investigated—Magnesium, Omega-3, Resveratrol, Quercetin, Zinc, Boron, Ginger, Curcumin, Progesterone, Sulforaphane, Butyrate, and Berberine

—three compounds stand out for their robust evidence in asthma models:  **Resveratrol** ,  **Quercetin** , and  **Curcumin** . 

These agents demonstrate synergistic effects with Vitamin D, reduce airway inflammation, and improve clinical outcomes in preclinical and clinical studies.

 **&lt;span style=&quot;color:#00F;&quot;&gt;Mechanisms of VDR Activation and Asthma Pathophysiology&lt;/span&gt;** 

The VDR plays a pivotal role in immune regulation and airway homeostasis. Polymorphisms in the VDR gene are associated with increased asthma susceptibility, highlighting its importance in disease modulation [5](https://pubmed.ncbi.nlm.nih.gov/15282199/) [14](https://www.spandidos-publications.com/10.3892/etm.2018.6867). Vitamin D itself enhances steroid responsiveness by upregulating glucocorticoid receptors (GR-α) and suppressing pro-inflammatory cytokines like IL-17F and IL-4 [7](https://onlinelibrary.wiley.com/doi/10.1155/2021/9947370) [22](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0111599). Supplements that potentiate VDR signaling may amplify these benefits, particularly in patients with Vitamin D deficiency or steroid resistance.

 **&lt;span style=&quot;color:#00F;&quot;&gt;Comparative Analysis of Key Supplements&lt;/span&gt;** 

 **1) Resveratrol** 

Resveratrol, a polyphenol found in grapes and berries, demonstrates multifaceted anti-asthmatic effects:

*  **Anti-Inflammatory Action** : Reduces eosinophil infiltration, Th2 cytokines (IL-4, IL-5, IL-13), and TGF-β1-driven epithelial-mesenchymal transition (EMT), a key process in airway remodeling [9](https://pmc.ncbi.nlm.nih.gov/articles/PMC5102830/) [10](https://pmc.ncbi.nlm.nih.gov/articles/PMC6306424/).

*  **Synergy with Vitamin D** : Enhances VDR-RXR heterodimerization and potentiates 1,25D binding to VDR, amplifying anti-inflammatory effects [11](https://pubmed.ncbi.nlm.nih.gov/25536521/).

*  **Clinical Relevance** : Suppresses airway hyperresponsiveness (AHR) and inflammation in murine models, with efficacy comparable to corticosteroids but with fewer side effects [10](https://pmc.ncbi.nlm.nih.gov/articles/PMC6306424/) [12](https://pmc.ncbi.nlm.nih.gov/articles/PMC7870687/).

 **2) Quercetin** 

Quercetin, a flavonoid abundant in fruits and vegetables, exhibits rapid bronchodilatory and immunomodulatory effects:

*  **Bronchodilation** : Inhibits phosphodiesterase-4 (PDE4), increasing cAMP levels and relaxing airway smooth muscle [17](https://pmc.ncbi.nlm.nih.gov/articles/PMC3763034/) [18](https://pmc.ncbi.nlm.nih.gov/articles/PMC7227109/).

*  **Immune Regulation** : Shifts Th1/Th2 balance by suppressing GATA-3 (Th2 transcription factor) and enhancing T-bet (Th1 promoter), reducing IgE and eosinophil levels [18](https://pmc.ncbi.nlm.nih.gov/articles/PMC7227109/) [20](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725497/).

*  **Oxidative Stress Mitigation** : Activates Nrf2/HO-1 pathways, reducing lipid peroxidation and enhancing antioxidant defenses [19](https://www.spandidos-publications.com/10.3892/mmr.2016.5563).

 **3) Curcumin** 

Curcumin, the active compound in turmeric, modulates critical inflammatory pathways:

*  **PPARγ Activation** : Suppresses NF-κB-driven inflammation and mucus hypersecretion in ovalbumin (OVA)-induced asthma models [4](https://pmc.ncbi.nlm.nih.gov/articles/PMC6470457/).

*  **Airway Remodeling** : Attenuates subepithelial fibrosis and collagen deposition by inhibiting TGF-β/Smad signaling [19](https://www.spandidos-publications.com/10.3892/mmr.2016.5563).

*  **Clinical Trials** : Reduces exacerbations and improves lung function in combination with standard therapies, though direct VDR interactions require further study [4](https://pmc.ncbi.nlm.nih.gov/articles/PMC6470457/).

 **&lt;span style=&quot;color:#00F;&quot;&gt;Supporting Evidence for Other Supplements&lt;/span&gt;** 

*  **Magnesium** : While serum magnesium levels correlate with asthma severity, its role is primarily as a bronchodilator rather than a direct VDR activator [3](https://journals.lww.com/ecdt/fulltext/2019/68040/serum_levels_of_vitamin_d,_magnesium,_and_calcium.12.aspx).

*  **Berberine** : Limited evidence in asthma; focuses on metabolic and antimicrobial benefits [21](https://www.buzzrx.com/blog/what-are-berberine-benefits-and-drawbacks).

*  **Zinc, Omega-3, Sulforaphane** : Absent from the provided studies in an asthma context, though theoretical immune benefits exist.

 **&lt;span style=&quot;color:#00F;&quot;&gt;Conclusion: Prioritizing Supplements for Asthma Management&lt;/span&gt;** 

Based on current evidence:

1.  **Resveratrol**  emerges as the most promising due to its dual anti-inflammatory and VDR-synergistic effects, particularly in steroid-resistant asthma.

1.  **Quercetin**  offers acute symptom relief and long-term immune modulation, making it ideal for exacerbation management.

1.  **Curcumin**  provides robust anti-remodeling effects, though further research is needed to clarify its VDR-specific mechanisms.

 **Clinical Implications** : Combining these supplements with Vitamin D supplementation may optimize outcomes, especially in deficient populations. Future trials should explore dose-response relationships and synergistic formulations.

 **&lt;span style=&quot;color:#00F;&quot;&gt;Future Directions&lt;/span&gt;** 

*  **Personalized Medicine** : Genetic screening for VDR polymorphisms could identify patients most likely to benefit from supplementation [5](https://pubmed.ncbi.nlm.nih.gov/15282199/) [14](https://www.spandidos-publications.com/10.3892/etm.2018.6867).

*  **Combination Therapies** : Investigating Resveratrol + Vitamin D or Quercetin + corticosteroids may enhance efficacy while minimizing steroid doses.

*  **Long-Term Safety** : Despite promising data, prolonged use of high-dose supplements requires rigorous safety assessments.

This analysis underscores the potential of natural compounds to complement conventional asthma therapies, offering a paradigm shift toward integrative

---

#### A poor VDR increases the risk of Asthma (but not the opposite assocation) - Feb 2025

What is the direction of the association between the Vitamin D receptor and Asthma? Does a poor VDR increase the risk of Asthma or does Asthma reduce the activation of the VDR?

 **[Perplexity Deep Research](https://www.perplexity.ai/search/what-is-the-direction-of-the-a-lmopy0OJROykvQnaEtYE5Q)** 

* [Parkinson&#39;s Disease might be treated by TENS](/posts/parkinsons-disease-might-be-treated-by-tens)



AST Structure:
-------------
├── DivNode
│   full_match: `{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}`
│   inner_content: `{maketoc Title=&quot;&quot;}`
│   attrs_dict:
│   │   raw_content: (class=&quot;lefth4&quot;)
│   │   class: lefth4
│   children:
│   ├── MakeTocNode
│   │   full_match: `{maketoc Title=&quot;&quot;}`
│   │   inner_content: ``
│   │   attrs_dict:
│   │   │   raw_content:  Title=&quot;&quot;
│   │   │   Title: ├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!~~#F06:10+~~  Vitamin D Receptor pages have ASTHMA  in the title`
│   inner_content: `~~#F06:10+~~  Vitamin D Receptor pages have ASTHMA  in the title`
│   level: `4`
│   children:
│   ├── ColorNode
│   │   full_match: `~~#F06:10+~~`
│   │   inner_content: `10+`
│   │   attrs_dict:
│   │   │   raw_content: #F06
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `10+`
│   │   │   inner_content: `10+`
│   ├── TextNode
│   │   full_match: `  Vitamin D Receptor pages have ASTHMA  in the title`
│   │   inner_content: `  Vitamin D Receptor pages have ASTHMA  in the title`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── EmphasisNode
│   full_match: `&#39;&#39;The list is automatically updated&#39;&#39;`
│   inner_content: `The list is automatically updated`
│   children:
│   ├── TextNode
│   │   full_match: `The list is automatically updated`
│   │   inner_content: `The list is automatically updated`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListNode
│   full_match: `{LIST()}\n{list max=&quot;50&quot;}\n{filter categories=&quot;142&quot;}\n{filter field=&quot;title&quot; content=&quot;asthma&quot;}\n{filter type=&quot;wiki page&quot;}\n{sort mode=&quot;modification_date_major_desc&quot;}\n{OUTPUT(template=&quot;table&quot;)}\n{tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}\n{column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}\n{column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}\n{OUTPUT}\n{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}\n{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}\n{LIST}`
│   inner_content: `\n{list max=&quot;50&quot;}\n{filter categories=&quot;142&quot;}\n{filter field=&quot;title&quot; content=&quot;asthma&quot;}\n{filter type=&quot;wiki page&quot;}\n{sort mode=&quot;modification_date_major_desc&quot;}\n{OUTPUT(template=&quot;table&quot;)}\n{tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}\n{column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}\n{column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}\n{OUTPUT}\n{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}\n{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}\n`
│   attrs_dict:
│   │   raw_content: 
│   children:
│   ├── TextNode
│   │   full_match: `\n{list max=&quot;50&quot;}\n{filter categories=&quot;142&quot;}\n{filter field=&quot;title&quot; content=&quot;asthma&quot;}\n{filter type=&quot;wiki page&quot;}\n{sort mode=&quot;modification_date_major_desc&quot;}\n{OUTPUT(template=&quot;table&quot;)}\n{tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}\n{column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}\n{column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}\n{OUTPUT}\n{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}\n{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}\n`
│   │   inner_content: `\n{list max=&quot;50&quot;}\n{filter categories=&quot;142&quot;}\n{filter field=&quot;title&quot; content=&quot;asthma&quot;}\n{filter type=&quot;wiki page&quot;}\n{sort mode=&quot;modification_date_major_desc&quot;}\n{OUTPUT(template=&quot;table&quot;)}\n{tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}\n{column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}\n{column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}\n{OUTPUT}\n{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}\n{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}\n`├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!Asthmatics with a poor Vitamin D Receptor were 4 X more likely to have exacerbation in 1 year - Jan 2025`
│   inner_content: `Asthmatics with a poor Vitamin D Receptor were 4 X more likely to have exacerbation in 1 year - Jan 2025`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `Asthmatics with a poor Vitamin D Receptor were 4 X more likely to have exacerbation in 1 year - Jan 2025`
│   │   inner_content: `Asthmatics with a poor Vitamin D Receptor were 4 X more likely to have exacerbation in 1 year - Jan 2025`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── BoldNode
│   full_match: `__Vitamin D Receptor rs2228570 Gene Polymorphism Is Associated with Asthma Severity and Exacerbations__`
│   inner_content: `Vitamin D Receptor rs2228570 Gene Polymorphism Is Associated with Asthma Severity and Exacerbations`
│   children:
│   ├── TextNode
│   │   full_match: `Vitamin D Receptor rs2228570 Gene Polymorphism Is Associated with Asthma Severity and Exacerbations`
│   │   inner_content: `Vitamin D Receptor rs2228570 Gene Polymorphism Is Associated with Asthma Severity and Exacerbations`├── TextNode
│   full_match: `\nSekiko Uehara, Keita Hirai  , Toshihiro Shirai, Hinako Otaki, Taisuke Akamatsu, Kunihiko Itoh \nBiological and Pharmaceutical Bulletin 2025 Volume 48 Issue 1 Pages 86-92 DOI https://doi.org/10.1248/bpb.b24-00684\n\n`
│   inner_content: `\nSekiko Uehara, Keita Hirai  , Toshihiro Shirai, Hinako Otaki, Taisuke Akamatsu, Kunihiko Itoh \nBiological and Pharmaceutical Bulletin 2025 Volume 48 Issue 1 Pages 86-92 DOI https://doi.org/10.1248/bpb.b24-00684\n\n`├── ImgNode
│   full_match: `{img type=&quot;attId&quot; attId=&quot;22239&quot; width=&quot;700&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  type=&quot;attId&quot; attId=&quot;22239&quot; width=&quot;700&quot;
│   │   type: attId
│   │   attId: 22239
│   │   width: 700├── TextNode
│   full_match: `\nVitamin D plays a crucial role in immune system function. Several studies have indicated that genetic variations in the vitamin D receptor (VDR) and vitamin D binding protein (VDBP, encoded by GC gene) increase the risk of developing asthma. However, the effect of these variations on the prognosis and clinical outcomes of asthma remains unclear. This study, involving 152 adult patients with asthma, aimed to assess the influence of VDR and GC polymorphisms on asthma severity and its exacerbation. Gene polymorphisms previously associated with asthma risk were analyzed, and VDR mRNA expression levels were evaluated in peripheral blood mononuclear cells. \nThe AA genotype of the VDR rs2228570 polymorphism was associated with an \n`
│   inner_content: `\nVitamin D plays a crucial role in immune system function. Several studies have indicated that genetic variations in the vitamin D receptor (VDR) and vitamin D binding protein (VDBP, encoded by GC gene) increase the risk of developing asthma. However, the effect of these variations on the prognosis and clinical outcomes of asthma remains unclear. This study, involving 152 adult patients with asthma, aimed to assess the influence of VDR and GC polymorphisms on asthma severity and its exacerbation. Gene polymorphisms previously associated with asthma risk were analyzed, and VDR mRNA expression levels were evaluated in peripheral blood mononuclear cells. \nThe AA genotype of the VDR rs2228570 polymorphism was associated with an \n`├── ListItemNode
│   full_match: `*__elevated risk of severe asthma__ compared to the AG/GG genotype (__ odds ratio, 3.20__; 95% confidence interval [CI], 1.24–8.28). `
│   inner_content: `__elevated risk of severe asthma__ compared to the AG/GG genotype (__ odds ratio, 3.20__; 95% confidence interval [CI], 1.24–8.28). `
│   depth: `1`
│   children:
│   ├── BoldNode
│   │   full_match: `__elevated risk of severe asthma__`
│   │   inner_content: `elevated risk of severe asthma`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `elevated risk of severe asthma`
│   │   │   inner_content: `elevated risk of severe asthma`
│   ├── TextNode
│   │   full_match: ` compared to the AG/GG genotype (`
│   │   inner_content: ` compared to the AG/GG genotype (`
│   ├── BoldNode
│   │   full_match: `__ odds ratio, 3.20__`
│   │   inner_content: ` odds ratio, 3.20`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `odds ratio, 3.20`
│   │   │   inner_content: `odds ratio, 3.20`
│   ├── TextNode
│   │   full_match: `; 95% confidence interval `
│   │   inner_content: `; 95% confidence interval `
│   ├── LinkNode
│   │   full_match: `[CI]`
│   │   inner_content: `CI`
│   │   url: `CI`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `CI`
│   │   │   inner_content: `CI`
│   ├── TextNode
│   │   full_match: `, 1.24–8.28). `
│   │   inner_content: `, 1.24–8.28). `├── TextNode
│   full_match: `\nFurthermore, patients with the rs2228570 AA genotype showed an \n`
│   inner_content: `\nFurthermore, patients with the rs2228570 AA genotype showed an \n`├── ListItemNode
│   full_match: `*__elevated risk of exacerbation__ during the 1-year follow-up period (__hazard ratio, 4.01__; 95% CI, 1.75–9.15). `
│   inner_content: `__elevated risk of exacerbation__ during the 1-year follow-up period (__hazard ratio, 4.01__; 95% CI, 1.75–9.15). `
│   depth: `1`
│   children:
│   ├── BoldNode
│   │   full_match: `__elevated risk of exacerbation__`
│   │   inner_content: `elevated risk of exacerbation`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `elevated risk of exacerbation`
│   │   │   inner_content: `elevated risk of exacerbation`
│   ├── TextNode
│   │   full_match: ` during the 1-year follow-up period (`
│   │   inner_content: ` during the 1-year follow-up period (`
│   ├── BoldNode
│   │   full_match: `__hazard ratio, 4.01__`
│   │   inner_content: `hazard ratio, 4.01`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `hazard ratio, 4.01`
│   │   │   inner_content: `hazard ratio, 4.01`
│   ├── TextNode
│   │   full_match: `; 95% CI, 1.75–9.15). `
│   │   inner_content: `; 95% CI, 1.75–9.15). `├── TextNode
│   full_match: `\nVDR mRNA expression was significantly reduced in patients with the AA genotype. Furthermore, the mRNA expression levels of GLCCI1, HDAC2, NR3C1, and NFE2L2, which are associated with steroid response, were reduced in patients with the AA genotype. \nOur findings indicate that patients with the AA genotype of VDR rs2228570 are more likely to experience severe asthma and exacerbations. This polymorphism has the potential to reduce vitamin D efficacy by altering VDR function and expression, potentially resulting in increased inflammation and reduced steroid responsiveness in patients with asthma.\n`
│   inner_content: `\nVDR mRNA expression was significantly reduced in patients with the AA genotype. Furthermore, the mRNA expression levels of GLCCI1, HDAC2, NR3C1, and NFE2L2, which are associated with steroid response, were reduced in patients with the AA genotype. \nOur findings indicate that patients with the AA genotype of VDR rs2228570 are more likely to experience severe asthma and exacerbations. This polymorphism has the potential to reduce vitamin D efficacy by altering VDR function and expression, potentially resulting in increased inflammation and reduced steroid responsiveness in patients with asthma.\n`├── FontNode
│   full_match: `{FONT(size=&quot;17&quot;)}__{ATTACH(inline=&quot;1&quot; id=&quot;22238&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__{FONT}`
│   inner_content: `__{ATTACH(inline=&quot;1&quot; id=&quot;22238&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__`
│   attrs_dict:
│   │   raw_content: size=&quot;17&quot;
│   │   size: 17
│   children:
│   ├── BoldNode
│   │   full_match: `__{ATTACH(inline=&quot;1&quot; id=&quot;22238&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__`
│   │   inner_content: `{ATTACH(inline=&quot;1&quot; id=&quot;22238&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}`
│   │   children:
│   │   ├── AttachNode
│   │   │   full_match: `{ATTACH(inline=&quot;1&quot; id=&quot;22238&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}`
│   │   │   inner_content: `Download the PDF from VitaminDWiki `
│   │   │   attrs_dict:
│   │   │   │   raw_content: (inline=&quot;1&quot; id=&quot;22238&quot; icon=&quot;1&quot;)
│   │   │   │   inline: 1
│   │   │   │   id: 22238
│   │   │   │   icon: 1
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Download the PDF from VitaminDWiki `
│   │   │   │   inner_content: `Download the PDF from VitaminDWiki `├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!Best VDR Activators for prevent/treat Asthma: Resveratrol, Quercetin, Curcumin - Feb 2025`
│   inner_content: `Best VDR Activators for prevent/treat Asthma: Resveratrol, Quercetin, Curcumin - Feb 2025`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `Best VDR Activators for prevent/treat Asthma: Resveratrol, Quercetin, Curcumin - Feb 2025`
│   │   inner_content: `Best VDR Activators for prevent/treat Asthma: Resveratrol, Quercetin, Curcumin - Feb 2025`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── BoldNode
│   full_match: `__Asked  [https://www.perplexity.ai/search/the-many-supplements-that-acti-WA7q8c_xTLa8uNrCprZL5Q|Perplexity AI - Deep Research]__`
│   inner_content: `Asked  [https://www.perplexity.ai/search/the-many-supplements-that-acti-WA7q8c_xTLa8uNrCprZL5Q|Perplexity AI - Deep Research]`
│   children:
│   ├── TextNode
│   │   full_match: `Asked  `
│   │   inner_content: `Asked  `
│   ├── LinkNode
│   │   full_match: `[https://www.perplexity.ai/search/the-many-supplements-that-acti-WA7q8c_xTLa8uNrCprZL5Q|Perplexity AI - Deep Research]`
│   │   inner_content: `Perplexity AI - Deep Research`
│   │   url: `https://www.perplexity.ai/search/the-many-supplements-that-acti-WA7q8c_xTLa8uNrCprZL5Q`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Perplexity AI - Deep Research`
│   │   │   inner_content: `Perplexity AI - Deep Research`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── BoldNode
│   full_match: `__The many supplements that activate the Vitamin D Receptor include Magnesium, Omega-3, Resveratrol, Quercetin , Zinc, Boron, ginger, curcumin, Progesterone, Sulfroaphane, Butyrate, and Berberine. Is there any hint as to which one is best for Asthma?__`
│   inner_content: `The many supplements that activate the Vitamin D Receptor include Magnesium, Omega-3, Resveratrol, Quercetin , Zinc, Boron, ginger, curcumin, Progesterone, Sulfroaphane, Butyrate, and Berberine. Is there any hint as to which one is best for Asthma?`
│   children:
│   ├── TextNode
│   │   full_match: `The many supplements that activate the Vitamin D Receptor include Magnesium, Omega-3, Resveratrol, Quercetin , Zinc, Boron, ginger, curcumin, Progesterone, Sulfroaphane, Butyrate, and Berberine. Is there any hint as to which one is best for Asthma?`
│   │   inner_content: `The many supplements that activate the Vitamin D Receptor include Magnesium, Omega-3, Resveratrol, Quercetin , Zinc, Boron, ginger, curcumin, Progesterone, Sulfroaphane, Butyrate, and Berberine. Is there any hint as to which one is best for Asthma?`├── TextNode
│   full_match: `\n\n`
│   inner_content: `\n\n`├── BoldNode
│   full_match: `__~~#F69:The Role of Vitamin D Receptor-Activating Supplements in Asthma Management: A Comprehensive Analysis~~__`
│   inner_content: `~~#F69:The Role of Vitamin D Receptor-Activating Supplements in Asthma Management: A Comprehensive Analysis~~`
│   children:
│   ├── ColorNode
│   │   full_match: `~~#F69:The Role of Vitamin D Receptor-Activating Supplements in Asthma Management: A Comprehensive Analysis~~`
│   │   inner_content: `The Role of Vitamin D Receptor-Activating Supplements in Asthma Management: A Comprehensive Analysis`
│   │   attrs_dict:
│   │   │   raw_content: #F69
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `The Role of Vitamin D Receptor-Activating Supplements in Asthma Management: A Comprehensive Analysis`
│   │   │   inner_content: `The Role of Vitamin D Receptor-Activating Supplements in Asthma Management: A Comprehensive Analysis`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── BoldNode
│   full_match: `__~~#00F:Summary of Key Findings~~__`
│   inner_content: `~~#00F:Summary of Key Findings~~`
│   children:
│   ├── ColorNode
│   │   full_match: `~~#00F:Summary of Key Findings~~`
│   │   inner_content: `Summary of Key Findings`
│   │   attrs_dict:
│   │   │   raw_content: #00F
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Summary of Key Findings`
│   │   │   inner_content: `Summary of Key Findings`├── TextNode
│   full_match: `\nEmerging research highlights the potential of various dietary supplements to modulate asthma pathophysiology through activation of the Vitamin D Receptor (VDR). Among the supplements investigated—Magnesium, Omega-3, Resveratrol, Quercetin, Zinc, Boron, Ginger, Curcumin, Progesterone, Sulforaphane, Butyrate, and Berberine\n—three compounds stand out for their robust evidence in asthma models: `
│   inner_content: `\nEmerging research highlights the potential of various dietary supplements to modulate asthma pathophysiology through activation of the Vitamin D Receptor (VDR). Among the supplements investigated—Magnesium, Omega-3, Resveratrol, Quercetin, Zinc, Boron, Ginger, Curcumin, Progesterone, Sulforaphane, Butyrate, and Berberine\n—three compounds stand out for their robust evidence in asthma models: `├── BoldNode
│   full_match: `__Resveratrol__`
│   inner_content: `Resveratrol`
│   children:
│   ├── TextNode
│   │   full_match: `Resveratrol`
│   │   inner_content: `Resveratrol`├── TextNode
│   full_match: `, `
│   inner_content: `, `├── BoldNode
│   full_match: `__Quercetin__`
│   inner_content: `Quercetin`
│   children:
│   ├── TextNode
│   │   full_match: `Quercetin`
│   │   inner_content: `Quercetin`├── TextNode
│   full_match: `, and `
│   inner_content: `, and `├── BoldNode
│   full_match: `__Curcumin__`
│   inner_content: `Curcumin`
│   children:
│   ├── TextNode
│   │   full_match: `Curcumin`
│   │   inner_content: `Curcumin`├── TextNode
│   full_match: `. \nThese agents demonstrate synergistic effects with Vitamin D, reduce airway inflammation, and improve clinical outcomes in preclinical and clinical studies.\n`
│   inner_content: `. \nThese agents demonstrate synergistic effects with Vitamin D, reduce airway inflammation, and improve clinical outcomes in preclinical and clinical studies.\n`├── BoldNode
│   full_match: `__~~#00F:Mechanisms of VDR Activation and Asthma Pathophysiology~~__`
│   inner_content: `~~#00F:Mechanisms of VDR Activation and Asthma Pathophysiology~~`
│   children:
│   ├── ColorNode
│   │   full_match: `~~#00F:Mechanisms of VDR Activation and Asthma Pathophysiology~~`
│   │   inner_content: `Mechanisms of VDR Activation and Asthma Pathophysiology`
│   │   attrs_dict:
│   │   │   raw_content: #00F
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Mechanisms of VDR Activation and Asthma Pathophysiology`
│   │   │   inner_content: `Mechanisms of VDR Activation and Asthma Pathophysiology`├── TextNode
│   full_match: `\nThe VDR plays a pivotal role in immune regulation and airway homeostasis. Polymorphisms in the VDR gene are associated with increased asthma susceptibility, highlighting its importance in disease modulation `
│   inner_content: `\nThe VDR plays a pivotal role in immune regulation and airway homeostasis. Polymorphisms in the VDR gene are associated with increased asthma susceptibility, highlighting its importance in disease modulation `├── LinkNode
│   full_match: `[https://pubmed.ncbi.nlm.nih.gov/15282199/|5]`
│   inner_content: `5`
│   url: `https://pubmed.ncbi.nlm.nih.gov/15282199/`
│   children:
│   ├── TextNode
│   │   full_match: `5`
│   │   inner_content: `5`├── TextNode
│   full_match: ` `
│   inner_content: ` `├── LinkNode
│   full_match: `[https://www.spandidos-publications.com/10.3892/etm.2018.6867|14]`
│   inner_content: `14`
│   url: `https://www.spandidos-publications.com/10.3892/etm.2018.6867`
│   children:
│   ├── TextNode
│   │   full_match: `14`
│   │   inner_content: `14`├── TextNode
│   full_match: `. Vitamin D itself enhances steroid responsiveness by upregulating glucocorticoid receptors (GR-α) and suppressing pro-inflammatory cytokines like IL-17F and IL-4 `
│   inner_content: `. Vitamin D itself enhances steroid responsiveness by upregulating glucocorticoid receptors (GR-α) and suppressing pro-inflammatory cytokines like IL-17F and IL-4 `├── LinkNode
│   full_match: `[https://onlinelibrary.wiley.com/doi/10.1155/2021/9947370|7]`
│   inner_content: `7`
│   url: `https://onlinelibrary.wiley.com/doi/10.1155/2021/9947370`
│   children:
│   ├── TextNode
│   │   full_match: `7`
│   │   inner_content: `7`├── TextNode
│   full_match: ` `
│   inner_content: ` `├── LinkNode
│   full_match: `[https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0111599|22]`
│   inner_content: `22`
│   url: `https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0111599`
│   children:
│   ├── TextNode
│   │   full_match: `22`
│   │   inner_content: `22`├── TextNode
│   full_match: `. Supplements that potentiate VDR signaling may amplify these benefits, particularly in patients with Vitamin D deficiency or steroid resistance.\n`
│   inner_content: `. Supplements that potentiate VDR signaling may amplify these benefits, particularly in patients with Vitamin D deficiency or steroid resistance.\n`├── BoldNode
│   full_match: `__~~#00F:Comparative Analysis of Key Supplements~~__`
│   inner_content: `~~#00F:Comparative Analysis of Key Supplements~~`
│   children:
│   ├── ColorNode
│   │   full_match: `~~#00F:Comparative Analysis of Key Supplements~~`
│   │   inner_content: `Comparative Analysis of Key Supplements`
│   │   attrs_dict:
│   │   │   raw_content: #00F
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Comparative Analysis of Key Supplements`
│   │   │   inner_content: `Comparative Analysis of Key Supplements`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── BoldNode
│   full_match: `__ 1) Resveratrol__`
│   inner_content: ` 1) Resveratrol`
│   children:
│   ├── TextNode
│   │   full_match: `1) Resveratrol`
│   │   inner_content: `1) Resveratrol`├── TextNode
│   full_match: `\nResveratrol, a polyphenol found in grapes and berries, demonstrates multifaceted anti-asthmatic effects:\n`
│   inner_content: `\nResveratrol, a polyphenol found in grapes and berries, demonstrates multifaceted anti-asthmatic effects:\n`├── ListItemNode
│   full_match: `*__Anti-Inflammatory Action__: Reduces eosinophil infiltration, Th2 cytokines (IL-4, IL-5, IL-13), and TGF-β1-driven epithelial-mesenchymal transition (EMT), a key process in airway remodeling [https://pmc.ncbi.nlm.nih.gov/articles/PMC5102830/|9] [https://pmc.ncbi.nlm.nih.gov/articles/PMC6306424/|10].`
│   inner_content: `__Anti-Inflammatory Action__: Reduces eosinophil infiltration, Th2 cytokines (IL-4, IL-5, IL-13), and TGF-β1-driven epithelial-mesenchymal transition (EMT), a key process in airway remodeling [https://pmc.ncbi.nlm.nih.gov/articles/PMC5102830/|9] [https://pmc.ncbi.nlm.nih.gov/articles/PMC6306424/|10].`
│   depth: `1`
│   children:
│   ├── BoldNode
│   │   full_match: `__Anti-Inflammatory Action__`
│   │   inner_content: `Anti-Inflammatory Action`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Anti-Inflammatory Action`
│   │   │   inner_content: `Anti-Inflammatory Action`
│   ├── TextNode
│   │   full_match: `: Reduces eosinophil infiltration, Th2 cytokines (IL-4, IL-5, IL-13), and TGF-β1-driven epithelial-mesenchymal transition (EMT), a key process in airway remodeling `
│   │   inner_content: `: Reduces eosinophil infiltration, Th2 cytokines (IL-4, IL-5, IL-13), and TGF-β1-driven epithelial-mesenchymal transition (EMT), a key process in airway remodeling `
│   ├── LinkNode
│   │   full_match: `[https://pmc.ncbi.nlm.nih.gov/articles/PMC5102830/|9]`
│   │   inner_content: `9`
│   │   url: `https://pmc.ncbi.nlm.nih.gov/articles/PMC5102830/`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `9`
│   │   │   inner_content: `9`
│   ├── TextNode
│   │   full_match: ` `
│   │   inner_content: ` `
│   ├── LinkNode
│   │   full_match: `[https://pmc.ncbi.nlm.nih.gov/articles/PMC6306424/|10]`
│   │   inner_content: `10`
│   │   url: `https://pmc.ncbi.nlm.nih.gov/articles/PMC6306424/`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `10`
│   │   │   inner_content: `10`
│   ├── TextNode
│   │   full_match: `.`
│   │   inner_content: `.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*__Synergy with Vitamin D__: Enhances VDR-RXR heterodimerization and potentiates 1,25D binding to VDR, amplifying anti-inflammatory effects [https://pubmed.ncbi.nlm.nih.gov/25536521/|11].`
│   inner_content: `__Synergy with Vitamin D__: Enhances VDR-RXR heterodimerization and potentiates 1,25D binding to VDR, amplifying anti-inflammatory effects [https://pubmed.ncbi.nlm.nih.gov/25536521/|11].`
│   depth: `1`
│   children:
│   ├── BoldNode
│   │   full_match: `__Synergy with Vitamin D__`
│   │   inner_content: `Synergy with Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Synergy with Vitamin D`
│   │   │   inner_content: `Synergy with Vitamin D`
│   ├── TextNode
│   │   full_match: `: Enhances VDR-RXR heterodimerization and potentiates 1,25D binding to VDR, amplifying anti-inflammatory effects `
│   │   inner_content: `: Enhances VDR-RXR heterodimerization and potentiates 1,25D binding to VDR, amplifying anti-inflammatory effects `
│   ├── LinkNode
│   │   full_match: `[https://pubmed.ncbi.nlm.nih.gov/25536521/|11]`
│   │   inner_content: `11`
│   │   url: `https://pubmed.ncbi.nlm.nih.gov/25536521/`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `11`
│   │   │   inner_content: `11`
│   ├── TextNode
│   │   full_match: `.`
│   │   inner_content: `.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*__Clinical Relevance__: Suppresses airway hyperresponsiveness (AHR) and inflammation in murine models, with efficacy comparable to corticosteroids but with fewer side effects [https://pmc.ncbi.nlm.nih.gov/articles/PMC6306424/|10] [https://pmc.ncbi.nlm.nih.gov/articles/PMC7870687/|12].`
│   inner_content: `__Clinical Relevance__: Suppresses airway hyperresponsiveness (AHR) and inflammation in murine models, with efficacy comparable to corticosteroids but with fewer side effects [https://pmc.ncbi.nlm.nih.gov/articles/PMC6306424/|10] [https://pmc.ncbi.nlm.nih.gov/articles/PMC7870687/|12].`
│   depth: `1`
│   children:
│   ├── BoldNode
│   │   full_match: `__Clinical Relevance__`
│   │   inner_content: `Clinical Relevance`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Clinical Relevance`
│   │   │   inner_content: `Clinical Relevance`
│   ├── TextNode
│   │   full_match: `: Suppresses airway hyperresponsiveness (AHR) and inflammation in murine models, with efficacy comparable to corticosteroids but with fewer side effects `
│   │   inner_content: `: Suppresses airway hyperresponsiveness (AHR) and inflammation in murine models, with efficacy comparable to corticosteroids but with fewer side effects `
│   ├── LinkNode
│   │   full_match: `[https://pmc.ncbi.nlm.nih.gov/articles/PMC6306424/|10]`
│   │   inner_content: `10`
│   │   url: `https://pmc.ncbi.nlm.nih.gov/articles/PMC6306424/`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `10`
│   │   │   inner_content: `10`
│   ├── TextNode
│   │   full_match: ` `
│   │   inner_content: ` `
│   ├── LinkNode
│   │   full_match: `[https://pmc.ncbi.nlm.nih.gov/articles/PMC7870687/|12]`
│   │   inner_content: `12`
│   │   url: `https://pmc.ncbi.nlm.nih.gov/articles/PMC7870687/`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `12`
│   │   │   inner_content: `12`
│   ├── TextNode
│   │   full_match: `.`
│   │   inner_content: `.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── BoldNode
│   full_match: `__2) Quercetin__`
│   inner_content: `2) Quercetin`
│   children:
│   ├── TextNode
│   │   full_match: `2) Quercetin`
│   │   inner_content: `2) Quercetin`├── TextNode
│   full_match: `\nQuercetin, a flavonoid abundant in fruits and vegetables, exhibits rapid bronchodilatory and immunomodulatory effects:\n`
│   inner_content: `\nQuercetin, a flavonoid abundant in fruits and vegetables, exhibits rapid bronchodilatory and immunomodulatory effects:\n`├── ListItemNode
│   full_match: `*__Bronchodilation__: Inhibits phosphodiesterase-4 (PDE4), increasing cAMP levels and relaxing airway smooth muscle [https://pmc.ncbi.nlm.nih.gov/articles/PMC3763034/|17] [https://pmc.ncbi.nlm.nih.gov/articles/PMC7227109/|18].`
│   inner_content: `__Bronchodilation__: Inhibits phosphodiesterase-4 (PDE4), increasing cAMP levels and relaxing airway smooth muscle [https://pmc.ncbi.nlm.nih.gov/articles/PMC3763034/|17] [https://pmc.ncbi.nlm.nih.gov/articles/PMC7227109/|18].`
│   depth: `1`
│   children:
│   ├── BoldNode
│   │   full_match: `__Bronchodilation__`
│   │   inner_content: `Bronchodilation`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Bronchodilation`
│   │   │   inner_content: `Bronchodilation`
│   ├── TextNode
│   │   full_match: `: Inhibits phosphodiesterase-4 (PDE4), increasing cAMP levels and relaxing airway smooth muscle `
│   │   inner_content: `: Inhibits phosphodiesterase-4 (PDE4), increasing cAMP levels and relaxing airway smooth muscle `
│   ├── LinkNode
│   │   full_match: `[https://pmc.ncbi.nlm.nih.gov/articles/PMC3763034/|17]`
│   │   inner_content: `17`
│   │   url: `https://pmc.ncbi.nlm.nih.gov/articles/PMC3763034/`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `17`
│   │   │   inner_content: `17`
│   ├── TextNode
│   │   full_match: ` `
│   │   inner_content: ` `
│   ├── LinkNode
│   │   full_match: `[https://pmc.ncbi.nlm.nih.gov/articles/PMC7227109/|18]`
│   │   inner_content: `18`
│   │   url: `https://pmc.ncbi.nlm.nih.gov/articles/PMC7227109/`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `18`
│   │   │   inner_content: `18`
│   ├── TextNode
│   │   full_match: `.`
│   │   inner_content: `.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*__Immune Regulation__: Shifts Th1/Th2 balance by suppressing GATA-3 (Th2 transcription factor) and enhancing T-bet (Th1 promoter), reducing IgE and eosinophil levels [https://pmc.ncbi.nlm.nih.gov/articles/PMC7227109/|18] [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725497/|20].`
│   inner_content: `__Immune Regulation__: Shifts Th1/Th2 balance by suppressing GATA-3 (Th2 transcription factor) and enhancing T-bet (Th1 promoter), reducing IgE and eosinophil levels [https://pmc.ncbi.nlm.nih.gov/articles/PMC7227109/|18] [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725497/|20].`
│   depth: `1`
│   children:
│   ├── BoldNode
│   │   full_match: `__Immune Regulation__`
│   │   inner_content: `Immune Regulation`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Immune Regulation`
│   │   │   inner_content: `Immune Regulation`
│   ├── TextNode
│   │   full_match: `: Shifts Th1/Th2 balance by suppressing GATA-3 (Th2 transcription factor) and enhancing T-bet (Th1 promoter), reducing IgE and eosinophil levels `
│   │   inner_content: `: Shifts Th1/Th2 balance by suppressing GATA-3 (Th2 transcription factor) and enhancing T-bet (Th1 promoter), reducing IgE and eosinophil levels `
│   ├── LinkNode
│   │   full_match: `[https://pmc.ncbi.nlm.nih.gov/articles/PMC7227109/|18]`
│   │   inner_content: `18`
│   │   url: `https://pmc.ncbi.nlm.nih.gov/articles/PMC7227109/`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `18`
│   │   │   inner_content: `18`
│   ├── TextNode
│   │   full_match: ` `
│   │   inner_content: ` `
│   ├── LinkNode
│   │   full_match: `[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725497/|20]`
│   │   inner_content: `20`
│   │   url: `https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725497/`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `20`
│   │   │   inner_content: `20`
│   ├── TextNode
│   │   full_match: `.`
│   │   inner_content: `.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*__Oxidative Stress Mitigation__: Activates Nrf2/HO-1 pathways, reducing lipid peroxidation and enhancing antioxidant defenses [https://www.spandidos-publications.com/10.3892/mmr.2016.5563|19].`
│   inner_content: `__Oxidative Stress Mitigation__: Activates Nrf2/HO-1 pathways, reducing lipid peroxidation and enhancing antioxidant defenses [https://www.spandidos-publications.com/10.3892/mmr.2016.5563|19].`
│   depth: `1`
│   children:
│   ├── BoldNode
│   │   full_match: `__Oxidative Stress Mitigation__`
│   │   inner_content: `Oxidative Stress Mitigation`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Oxidative Stress Mitigation`
│   │   │   inner_content: `Oxidative Stress Mitigation`
│   ├── TextNode
│   │   full_match: `: Activates Nrf2/HO-1 pathways, reducing lipid peroxidation and enhancing antioxidant defenses `
│   │   inner_content: `: Activates Nrf2/HO-1 pathways, reducing lipid peroxidation and enhancing antioxidant defenses `
│   ├── LinkNode
│   │   full_match: `[https://www.spandidos-publications.com/10.3892/mmr.2016.5563|19]`
│   │   inner_content: `19`
│   │   url: `https://www.spandidos-publications.com/10.3892/mmr.2016.5563`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `19`
│   │   │   inner_content: `19`
│   ├── TextNode
│   │   full_match: `.`
│   │   inner_content: `.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── BoldNode
│   full_match: `__3) Curcumin__`
│   inner_content: `3) Curcumin`
│   children:
│   ├── TextNode
│   │   full_match: `3) Curcumin`
│   │   inner_content: `3) Curcumin`├── TextNode
│   full_match: `\nCurcumin, the active compound in turmeric, modulates critical inflammatory pathways:\n`
│   inner_content: `\nCurcumin, the active compound in turmeric, modulates critical inflammatory pathways:\n`├── ListItemNode
│   full_match: `*__PPARγ Activation__: Suppresses NF-κB-driven inflammation and mucus hypersecretion in ovalbumin (OVA)-induced asthma models [https://pmc.ncbi.nlm.nih.gov/articles/PMC6470457/|4].`
│   inner_content: `__PPARγ Activation__: Suppresses NF-κB-driven inflammation and mucus hypersecretion in ovalbumin (OVA)-induced asthma models [https://pmc.ncbi.nlm.nih.gov/articles/PMC6470457/|4].`
│   depth: `1`
│   children:
│   ├── BoldNode
│   │   full_match: `__PPARγ Activation__`
│   │   inner_content: `PPARγ Activation`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `PPARγ Activation`
│   │   │   inner_content: `PPARγ Activation`
│   ├── TextNode
│   │   full_match: `: Suppresses NF-κB-driven inflammation and mucus hypersecretion in ovalbumin (OVA)-induced asthma models `
│   │   inner_content: `: Suppresses NF-κB-driven inflammation and mucus hypersecretion in ovalbumin (OVA)-induced asthma models `
│   ├── LinkNode
│   │   full_match: `[https://pmc.ncbi.nlm.nih.gov/articles/PMC6470457/|4]`
│   │   inner_content: `4`
│   │   url: `https://pmc.ncbi.nlm.nih.gov/articles/PMC6470457/`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `4`
│   │   │   inner_content: `4`
│   ├── TextNode
│   │   full_match: `.`
│   │   inner_content: `.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*__Airway Remodeling__: Attenuates subepithelial fibrosis and collagen deposition by inhibiting TGF-β/Smad signaling [https://www.spandidos-publications.com/10.3892/mmr.2016.5563|19].`
│   inner_content: `__Airway Remodeling__: Attenuates subepithelial fibrosis and collagen deposition by inhibiting TGF-β/Smad signaling [https://www.spandidos-publications.com/10.3892/mmr.2016.5563|19].`
│   depth: `1`
│   children:
│   ├── BoldNode
│   │   full_match: `__Airway Remodeling__`
│   │   inner_content: `Airway Remodeling`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Airway Remodeling`
│   │   │   inner_content: `Airway Remodeling`
│   ├── TextNode
│   │   full_match: `: Attenuates subepithelial fibrosis and collagen deposition by inhibiting TGF-β/Smad signaling `
│   │   inner_content: `: Attenuates subepithelial fibrosis and collagen deposition by inhibiting TGF-β/Smad signaling `
│   ├── LinkNode
│   │   full_match: `[https://www.spandidos-publications.com/10.3892/mmr.2016.5563|19]`
│   │   inner_content: `19`
│   │   url: `https://www.spandidos-publications.com/10.3892/mmr.2016.5563`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `19`
│   │   │   inner_content: `19`
│   ├── TextNode
│   │   full_match: `.`
│   │   inner_content: `.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*__Clinical Trials__: Reduces exacerbations and improves lung function in combination with standard therapies, though direct VDR interactions require further study [https://pmc.ncbi.nlm.nih.gov/articles/PMC6470457/|4].`
│   inner_content: `__Clinical Trials__: Reduces exacerbations and improves lung function in combination with standard therapies, though direct VDR interactions require further study [https://pmc.ncbi.nlm.nih.gov/articles/PMC6470457/|4].`
│   depth: `1`
│   children:
│   ├── BoldNode
│   │   full_match: `__Clinical Trials__`
│   │   inner_content: `Clinical Trials`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Clinical Trials`
│   │   │   inner_content: `Clinical Trials`
│   ├── TextNode
│   │   full_match: `: Reduces exacerbations and improves lung function in combination with standard therapies, though direct VDR interactions require further study `
│   │   inner_content: `: Reduces exacerbations and improves lung function in combination with standard therapies, though direct VDR interactions require further study `
│   ├── LinkNode
│   │   full_match: `[https://pmc.ncbi.nlm.nih.gov/articles/PMC6470457/|4]`
│   │   inner_content: `4`
│   │   url: `https://pmc.ncbi.nlm.nih.gov/articles/PMC6470457/`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `4`
│   │   │   inner_content: `4`
│   ├── TextNode
│   │   full_match: `.`
│   │   inner_content: `.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── BoldNode
│   full_match: `__~~#00F:Supporting Evidence for Other Supplements~~__`
│   inner_content: `~~#00F:Supporting Evidence for Other Supplements~~`
│   children:
│   ├── ColorNode
│   │   full_match: `~~#00F:Supporting Evidence for Other Supplements~~`
│   │   inner_content: `Supporting Evidence for Other Supplements`
│   │   attrs_dict:
│   │   │   raw_content: #00F
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Supporting Evidence for Other Supplements`
│   │   │   inner_content: `Supporting Evidence for Other Supplements`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*__Magnesium__: While serum magnesium levels correlate with asthma severity, its role is primarily as a bronchodilator rather than a direct VDR activator [https://journals.lww.com/ecdt/fulltext/2019/68040/serum_levels_of_vitamin_d,_magnesium,_and_calcium.12.aspx|3].`
│   inner_content: `__Magnesium__: While serum magnesium levels correlate with asthma severity, its role is primarily as a bronchodilator rather than a direct VDR activator [https://journals.lww.com/ecdt/fulltext/2019/68040/serum_levels_of_vitamin_d,_magnesium,_and_calcium.12.aspx|3].`
│   depth: `1`
│   children:
│   ├── BoldNode
│   │   full_match: `__Magnesium__`
│   │   inner_content: `Magnesium`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Magnesium`
│   │   │   inner_content: `Magnesium`
│   ├── TextNode
│   │   full_match: `: While serum magnesium levels correlate with asthma severity, its role is primarily as a bronchodilator rather than a direct VDR activator `
│   │   inner_content: `: While serum magnesium levels correlate with asthma severity, its role is primarily as a bronchodilator rather than a direct VDR activator `
│   ├── LinkNode
│   │   full_match: `[https://journals.lww.com/ecdt/fulltext/2019/68040/serum_levels_of_vitamin_d,_magnesium,_and_calcium.12.aspx|3]`
│   │   inner_content: `3`
│   │   url: `https://journals.lww.com/ecdt/fulltext/2019/68040/serum_levels_of_vitamin_d,_magnesium,_and_calcium.12.aspx`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `3`
│   │   │   inner_content: `3`
│   ├── TextNode
│   │   full_match: `.`
│   │   inner_content: `.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*__Berberine__: Limited evidence in asthma; focuses on metabolic and antimicrobial benefits [https://www.buzzrx.com/blog/what-are-berberine-benefits-and-drawbacks|21].`
│   inner_content: `__Berberine__: Limited evidence in asthma; focuses on metabolic and antimicrobial benefits [https://www.buzzrx.com/blog/what-are-berberine-benefits-and-drawbacks|21].`
│   depth: `1`
│   children:
│   ├── BoldNode
│   │   full_match: `__Berberine__`
│   │   inner_content: `Berberine`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Berberine`
│   │   │   inner_content: `Berberine`
│   ├── TextNode
│   │   full_match: `: Limited evidence in asthma; focuses on metabolic and antimicrobial benefits `
│   │   inner_content: `: Limited evidence in asthma; focuses on metabolic and antimicrobial benefits `
│   ├── LinkNode
│   │   full_match: `[https://www.buzzrx.com/blog/what-are-berberine-benefits-and-drawbacks|21]`
│   │   inner_content: `21`
│   │   url: `https://www.buzzrx.com/blog/what-are-berberine-benefits-and-drawbacks`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `21`
│   │   │   inner_content: `21`
│   ├── TextNode
│   │   full_match: `.`
│   │   inner_content: `.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*__Zinc, Omega-3, Sulforaphane__: Absent from the provided studies in an asthma context, though theoretical immune benefits exist.`
│   inner_content: `__Zinc, Omega-3, Sulforaphane__: Absent from the provided studies in an asthma context, though theoretical immune benefits exist.`
│   depth: `1`
│   children:
│   ├── BoldNode
│   │   full_match: `__Zinc, Omega-3, Sulforaphane__`
│   │   inner_content: `Zinc, Omega-3, Sulforaphane`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Zinc, Omega-3, Sulforaphane`
│   │   │   inner_content: `Zinc, Omega-3, Sulforaphane`
│   ├── TextNode
│   │   full_match: `: Absent from the provided studies in an asthma context, though theoretical immune benefits exist.`
│   │   inner_content: `: Absent from the provided studies in an asthma context, though theoretical immune benefits exist.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── BoldNode
│   full_match: `__~~#00F:Conclusion: Prioritizing Supplements for Asthma Management~~__`
│   inner_content: `~~#00F:Conclusion: Prioritizing Supplements for Asthma Management~~`
│   children:
│   ├── ColorNode
│   │   full_match: `~~#00F:Conclusion: Prioritizing Supplements for Asthma Management~~`
│   │   inner_content: `Conclusion: Prioritizing Supplements for Asthma Management`
│   │   attrs_dict:
│   │   │   raw_content: #00F
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Conclusion: Prioritizing Supplements for Asthma Management`
│   │   │   inner_content: `Conclusion: Prioritizing Supplements for Asthma Management`├── TextNode
│   full_match: `\nBased on current evidence:\n`
│   inner_content: `\nBased on current evidence:\n`├── NumListItemNode
│   full_match: `#__Resveratrol__ emerges as the most promising due to its dual anti-inflammatory and VDR-synergistic effects, particularly in steroid-resistant asthma.`
│   inner_content: `__Resveratrol__ emerges as the most promising due to its dual anti-inflammatory and VDR-synergistic effects, particularly in steroid-resistant asthma.`
│   depth: `1`
│   children:
│   ├── BoldNode
│   │   full_match: `__Resveratrol__`
│   │   inner_content: `Resveratrol`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Resveratrol`
│   │   │   inner_content: `Resveratrol`
│   ├── TextNode
│   │   full_match: ` emerges as the most promising due to its dual anti-inflammatory and VDR-synergistic effects, particularly in steroid-resistant asthma.`
│   │   inner_content: ` emerges as the most promising due to its dual anti-inflammatory and VDR-synergistic effects, particularly in steroid-resistant asthma.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#__Quercetin__ offers acute symptom relief and long-term immune modulation, making it ideal for exacerbation management.`
│   inner_content: `__Quercetin__ offers acute symptom relief and long-term immune modulation, making it ideal for exacerbation management.`
│   depth: `1`
│   children:
│   ├── BoldNode
│   │   full_match: `__Quercetin__`
│   │   inner_content: `Quercetin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Quercetin`
│   │   │   inner_content: `Quercetin`
│   ├── TextNode
│   │   full_match: ` offers acute symptom relief and long-term immune modulation, making it ideal for exacerbation management.`
│   │   inner_content: ` offers acute symptom relief and long-term immune modulation, making it ideal for exacerbation management.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── NumListItemNode
│   full_match: `#__Curcumin__ provides robust anti-remodeling effects, though further research is needed to clarify its VDR-specific mechanisms.`
│   inner_content: `__Curcumin__ provides robust anti-remodeling effects, though further research is needed to clarify its VDR-specific mechanisms.`
│   depth: `1`
│   children:
│   ├── BoldNode
│   │   full_match: `__Curcumin__`
│   │   inner_content: `Curcumin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Curcumin`
│   │   │   inner_content: `Curcumin`
│   ├── TextNode
│   │   full_match: ` provides robust anti-remodeling effects, though further research is needed to clarify its VDR-specific mechanisms.`
│   │   inner_content: ` provides robust anti-remodeling effects, though further research is needed to clarify its VDR-specific mechanisms.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── BoldNode
│   full_match: `__Clinical Implications__`
│   inner_content: `Clinical Implications`
│   children:
│   ├── TextNode
│   │   full_match: `Clinical Implications`
│   │   inner_content: `Clinical Implications`├── TextNode
│   full_match: `: Combining these supplements with Vitamin D supplementation may optimize outcomes, especially in deficient populations. Future trials should explore dose-response relationships and synergistic formulations.\n`
│   inner_content: `: Combining these supplements with Vitamin D supplementation may optimize outcomes, especially in deficient populations. Future trials should explore dose-response relationships and synergistic formulations.\n`├── BoldNode
│   full_match: `__~~#00F:Future Directions~~__`
│   inner_content: `~~#00F:Future Directions~~`
│   children:
│   ├── ColorNode
│   │   full_match: `~~#00F:Future Directions~~`
│   │   inner_content: `Future Directions`
│   │   attrs_dict:
│   │   │   raw_content: #00F
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Future Directions`
│   │   │   inner_content: `Future Directions`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*__Personalized Medicine__: Genetic screening for VDR polymorphisms could identify patients most likely to benefit from supplementation [https://pubmed.ncbi.nlm.nih.gov/15282199/|5] [https://www.spandidos-publications.com/10.3892/etm.2018.6867|14].`
│   inner_content: `__Personalized Medicine__: Genetic screening for VDR polymorphisms could identify patients most likely to benefit from supplementation [https://pubmed.ncbi.nlm.nih.gov/15282199/|5] [https://www.spandidos-publications.com/10.3892/etm.2018.6867|14].`
│   depth: `1`
│   children:
│   ├── BoldNode
│   │   full_match: `__Personalized Medicine__`
│   │   inner_content: `Personalized Medicine`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Personalized Medicine`
│   │   │   inner_content: `Personalized Medicine`
│   ├── TextNode
│   │   full_match: `: Genetic screening for VDR polymorphisms could identify patients most likely to benefit from supplementation `
│   │   inner_content: `: Genetic screening for VDR polymorphisms could identify patients most likely to benefit from supplementation `
│   ├── LinkNode
│   │   full_match: `[https://pubmed.ncbi.nlm.nih.gov/15282199/|5]`
│   │   inner_content: `5`
│   │   url: `https://pubmed.ncbi.nlm.nih.gov/15282199/`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `5`
│   │   │   inner_content: `5`
│   ├── TextNode
│   │   full_match: ` `
│   │   inner_content: ` `
│   ├── LinkNode
│   │   full_match: `[https://www.spandidos-publications.com/10.3892/etm.2018.6867|14]`
│   │   inner_content: `14`
│   │   url: `https://www.spandidos-publications.com/10.3892/etm.2018.6867`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `14`
│   │   │   inner_content: `14`
│   ├── TextNode
│   │   full_match: `.`
│   │   inner_content: `.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*__Combination Therapies__: Investigating Resveratrol + Vitamin D or Quercetin + corticosteroids may enhance efficacy while minimizing steroid doses.`
│   inner_content: `__Combination Therapies__: Investigating Resveratrol + Vitamin D or Quercetin + corticosteroids may enhance efficacy while minimizing steroid doses.`
│   depth: `1`
│   children:
│   ├── BoldNode
│   │   full_match: `__Combination Therapies__`
│   │   inner_content: `Combination Therapies`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Combination Therapies`
│   │   │   inner_content: `Combination Therapies`
│   ├── TextNode
│   │   full_match: `: Investigating Resveratrol + Vitamin D or Quercetin + corticosteroids may enhance efficacy while minimizing steroid doses.`
│   │   inner_content: `: Investigating Resveratrol + Vitamin D or Quercetin + corticosteroids may enhance efficacy while minimizing steroid doses.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*__Long-Term Safety__: Despite promising data, prolonged use of high-dose supplements requires rigorous safety assessments.`
│   inner_content: `__Long-Term Safety__: Despite promising data, prolonged use of high-dose supplements requires rigorous safety assessments.`
│   depth: `1`
│   children:
│   ├── BoldNode
│   │   full_match: `__Long-Term Safety__`
│   │   inner_content: `Long-Term Safety`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Long-Term Safety`
│   │   │   inner_content: `Long-Term Safety`
│   ├── TextNode
│   │   full_match: `: Despite promising data, prolonged use of high-dose supplements requires rigorous safety assessments.`
│   │   inner_content: `: Despite promising data, prolonged use of high-dose supplements requires rigorous safety assessments.`├── TextNode
│   full_match: `\nThis analysis underscores the potential of natural compounds to complement conventional asthma therapies, offering a paradigm shift toward integrative`
│   inner_content: `\nThis analysis underscores the potential of natural compounds to complement conventional asthma therapies, offering a paradigm shift toward integrative`├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!VitaminDWiki – ((Overview Asthma and Vitamin D))  contains`
│   inner_content: `VitaminDWiki – ((Overview Asthma and Vitamin D))  contains`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `VitaminDWiki – `
│   │   inner_content: `VitaminDWiki – `
│   ├── LocalLinkNode
│   │   full_match: `((Overview Asthma and Vitamin D))`
│   │   inner_content: `Overview Asthma and Vitamin D`
│   │   page: `Overview Asthma and Vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Overview Asthma and Vitamin D`
│   │   │   inner_content: `Overview Asthma and Vitamin D`
│   ├── TextNode
│   │   full_match: `  contains`
│   │   inner_content: `  contains`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── IncludeNode
│   full_match: `{include page=&quot;Overview Asthma and Vitamin D&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  page=&quot;Overview Asthma and Vitamin D&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;
│   │   page: Overview Asthma and Vitamin D
│   │   start: ~tc~ start ~/tc~
│   │   stop: ~tc~ end ~/tc~
│   children:
│   ├── TextNode
│   │   full_match: ``
│   │   inner_content: ``├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!VitaminDWiki - The risk of ~~#F00:50+ ~~ diseases at least double with poor ((Vitamin D Receptor))`
│   inner_content: `VitaminDWiki - The risk of ~~#F00:50+ ~~ diseases at least double with poor ((Vitamin D Receptor))`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `VitaminDWiki - The risk of `
│   │   inner_content: `VitaminDWiki - The risk of `
│   ├── ColorNode
│   │   full_match: `~~#F00:50+ ~~`
│   │   inner_content: `50+ `
│   │   attrs_dict:
│   │   │   raw_content: #F00
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `50+ `
│   │   │   inner_content: `50+ `
│   ├── TextNode
│   │   full_match: ` diseases at least double with poor `
│   │   inner_content: ` diseases at least double with poor `
│   ├── LocalLinkNode
│   │   full_match: `((Vitamin D Receptor))`
│   │   inner_content: `Vitamin D Receptor`
│   │   page: `Vitamin D Receptor`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D Receptor`
│   │   │   inner_content: `Vitamin D Receptor`├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!A poor VDR increases the risk of Asthma (but not the opposite assocation) - Feb 2025`
│   inner_content: `A poor VDR increases the risk of Asthma (but not the opposite assocation) - Feb 2025`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `A poor VDR increases the risk of Asthma (but not the opposite assocation) - Feb 2025`
│   │   inner_content: `A poor VDR increases the risk of Asthma (but not the opposite assocation) - Feb 2025`├── TextNode
│   full_match: `\nWhat is the direction of the association between the Vitamin D receptor and Asthma? Does a poor VDR increase the risk of Asthma or does Asthma reduce the activation of the VDR?\n`
│   inner_content: `\nWhat is the direction of the association between the Vitamin D receptor and Asthma? Does a poor VDR increase the risk of Asthma or does Asthma reduce the activation of the VDR?\n`├── BoldNode
│   full_match: `__[https://www.perplexity.ai/search/what-is-the-direction-of-the-a-lmopy0OJROykvQnaEtYE5Q|Perplexity Deep Research]__`
│   inner_content: `[https://www.perplexity.ai/search/what-is-the-direction-of-the-a-lmopy0OJROykvQnaEtYE5Q|Perplexity Deep Research]`
│   children:
│   ├── LinkNode
│   │   full_match: `[https://www.perplexity.ai/search/what-is-the-direction-of-the-a-lmopy0OJROykvQnaEtYE5Q|Perplexity Deep Research]`
│   │   inner_content: `Perplexity Deep Research`
│   │   url: `https://www.perplexity.ai/search/what-is-the-direction-of-the-a-lmopy0OJROykvQnaEtYE5Q`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Perplexity Deep Research`
│   │   │   inner_content: `Perplexity Deep Research`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*((Parkinson&#39;s Disease might be treated by TENS))`
│   inner_content: `((Parkinson&#39;s Disease might be treated by TENS))`
│   depth: `1`
│   children:
│   ├── LocalLinkNode
│   │   full_match: `((Parkinson&#39;s Disease might be treated by TENS))`
│   │   inner_content: `Parkinson&#39;s Disease might be treated by TENS`
│   │   page: `Parkinson&#39;s Disease might be treated by TENS`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Parkinson&#39;s Disease might be treated by TENS`
│   │   │   inner_content: `Parkinson&#39;s Disease might be treated by TENS`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`

Original Tiki:
-------------
{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}
---
!!!!~~#F06:10+~~  Vitamin D Receptor pages have ASTHMA  in the title
&#39;&#39;The list is automatically updated&#39;&#39;
{LIST()}
{list max=&quot;50&quot;}
{filter categories=&quot;142&quot;}
{filter field=&quot;title&quot; content=&quot;asthma&quot;}
{filter type=&quot;wiki page&quot;}
{sort mode=&quot;modification_date_major_desc&quot;}
{OUTPUT(template=&quot;table&quot;)}
   {tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}
    {column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}
    {column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}
{OUTPUT}
{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}
{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}
{LIST}
---
!!!!Asthmatics with a poor Vitamin D Receptor were 4 X more likely to have exacerbation in 1 year - Jan 2025
__Vitamin D Receptor rs2228570 Gene Polymorphism Is Associated with Asthma Severity and Exacerbations__
Sekiko Uehara, Keita Hirai  , Toshihiro Shirai, Hinako Otaki, Taisuke Akamatsu, Kunihiko Itoh 
Biological and Pharmaceutical Bulletin 2025 Volume 48 Issue 1 Pages 86-92 DOI https://doi.org/10.1248/bpb.b24-00684

{img type=&quot;attId&quot; attId=&quot;22239&quot; width=&quot;700&quot;}
Vitamin D plays a crucial role in immune system function. Several studies have indicated that genetic variations in the vitamin D receptor (VDR) and vitamin D binding protein (VDBP, encoded by GC gene) increase the risk of developing asthma. However, the effect of these variations on the prognosis and clinical outcomes of asthma remains unclear. This study, involving 152 adult patients with asthma, aimed to assess the influence of VDR and GC polymorphisms on asthma severity and its exacerbation. Gene polymorphisms previously associated with asthma risk were analyzed, and VDR mRNA expression levels were evaluated in peripheral blood mononuclear cells. 
The AA genotype of the VDR rs2228570 polymorphism was associated with an 
*__elevated risk of severe asthma__ compared to the AG/GG genotype (__ odds ratio, 3.20__; 95% confidence interval [CI], 1.24–8.28). 
Furthermore, patients with the rs2228570 AA genotype showed an 
*__elevated risk of exacerbation__ during the 1-year follow-up period (__hazard ratio, 4.01__; 95% CI, 1.75–9.15). 
VDR mRNA expression was significantly reduced in patients with the AA genotype. Furthermore, the mRNA expression levels of GLCCI1, HDAC2, NR3C1, and NFE2L2, which are associated with steroid response, were reduced in patients with the AA genotype. 
Our findings indicate that patients with the AA genotype of VDR rs2228570 are more likely to experience severe asthma and exacerbations. This polymorphism has the potential to reduce vitamin D efficacy by altering VDR function and expression, potentially resulting in increased inflammation and reduced steroid responsiveness in patients with asthma.
{FONT(size=&quot;17&quot;)}__{ATTACH(inline=&quot;1&quot; id=&quot;22238&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__{FONT}
---
!!!!Best VDR Activators for prevent/treat Asthma: Resveratrol, Quercetin, Curcumin - Feb 2025
__Asked  [https://www.perplexity.ai/search/the-many-supplements-that-acti-WA7q8c_xTLa8uNrCprZL5Q|Perplexity AI - Deep Research]__
__The many supplements that activate the Vitamin D Receptor include Magnesium, Omega-3, Resveratrol, Quercetin , Zinc, Boron, ginger, curcumin, Progesterone, Sulfroaphane, Butyrate, and Berberine. Is there any hint as to which one is best for Asthma?__

__~~#F69:The Role of Vitamin D Receptor-Activating Supplements in Asthma Management: A Comprehensive Analysis~~__
__~~#00F:Summary of Key Findings~~__
Emerging research highlights the potential of various dietary supplements to modulate asthma pathophysiology through activation of the Vitamin D Receptor (VDR). Among the supplements investigated—Magnesium, Omega-3, Resveratrol, Quercetin, Zinc, Boron, Ginger, Curcumin, Progesterone, Sulforaphane, Butyrate, and Berberine
—three compounds stand out for their robust evidence in asthma models: __Resveratrol__, __Quercetin__, and __Curcumin__. 
These agents demonstrate synergistic effects with Vitamin D, reduce airway inflammation, and improve clinical outcomes in preclinical and clinical studies.
__~~#00F:Mechanisms of VDR Activation and Asthma Pathophysiology~~__
The VDR plays a pivotal role in immune regulation and airway homeostasis. Polymorphisms in the VDR gene are associated with increased asthma susceptibility, highlighting its importance in disease modulation [https://pubmed.ncbi.nlm.nih.gov/15282199/|5] [https://www.spandidos-publications.com/10.3892/etm.2018.6867|14]. Vitamin D itself enhances steroid responsiveness by upregulating glucocorticoid receptors (GR-α) and suppressing pro-inflammatory cytokines like IL-17F and IL-4 [https://onlinelibrary.wiley.com/doi/10.1155/2021/9947370|7] [https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0111599|22]. Supplements that potentiate VDR signaling may amplify these benefits, particularly in patients with Vitamin D deficiency or steroid resistance.
__~~#00F:Comparative Analysis of Key Supplements~~__
__ 1) Resveratrol__
Resveratrol, a polyphenol found in grapes and berries, demonstrates multifaceted anti-asthmatic effects:
*__Anti-Inflammatory Action__: Reduces eosinophil infiltration, Th2 cytokines (IL-4, IL-5, IL-13), and TGF-β1-driven epithelial-mesenchymal transition (EMT), a key process in airway remodeling [https://pmc.ncbi.nlm.nih.gov/articles/PMC5102830/|9] [https://pmc.ncbi.nlm.nih.gov/articles/PMC6306424/|10].
*__Synergy with Vitamin D__: Enhances VDR-RXR heterodimerization and potentiates 1,25D binding to VDR, amplifying anti-inflammatory effects [https://pubmed.ncbi.nlm.nih.gov/25536521/|11].
*__Clinical Relevance__: Suppresses airway hyperresponsiveness (AHR) and inflammation in murine models, with efficacy comparable to corticosteroids but with fewer side effects [https://pmc.ncbi.nlm.nih.gov/articles/PMC6306424/|10] [https://pmc.ncbi.nlm.nih.gov/articles/PMC7870687/|12].
__2) Quercetin__
Quercetin, a flavonoid abundant in fruits and vegetables, exhibits rapid bronchodilatory and immunomodulatory effects:
*__Bronchodilation__: Inhibits phosphodiesterase-4 (PDE4), increasing cAMP levels and relaxing airway smooth muscle [https://pmc.ncbi.nlm.nih.gov/articles/PMC3763034/|17] [https://pmc.ncbi.nlm.nih.gov/articles/PMC7227109/|18].
*__Immune Regulation__: Shifts Th1/Th2 balance by suppressing GATA-3 (Th2 transcription factor) and enhancing T-bet (Th1 promoter), reducing IgE and eosinophil levels [https://pmc.ncbi.nlm.nih.gov/articles/PMC7227109/|18] [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725497/|20].
*__Oxidative Stress Mitigation__: Activates Nrf2/HO-1 pathways, reducing lipid peroxidation and enhancing antioxidant defenses [https://www.spandidos-publications.com/10.3892/mmr.2016.5563|19].
__3) Curcumin__
Curcumin, the active compound in turmeric, modulates critical inflammatory pathways:
*__PPARγ Activation__: Suppresses NF-κB-driven inflammation and mucus hypersecretion in ovalbumin (OVA)-induced asthma models [https://pmc.ncbi.nlm.nih.gov/articles/PMC6470457/|4].
*__Airway Remodeling__: Attenuates subepithelial fibrosis and collagen deposition by inhibiting TGF-β/Smad signaling [https://www.spandidos-publications.com/10.3892/mmr.2016.5563|19].
*__Clinical Trials__: Reduces exacerbations and improves lung function in combination with standard therapies, though direct VDR interactions require further study [https://pmc.ncbi.nlm.nih.gov/articles/PMC6470457/|4].
__~~#00F:Supporting Evidence for Other Supplements~~__
*__Magnesium__: While serum magnesium levels correlate with asthma severity, its role is primarily as a bronchodilator rather than a direct VDR activator [https://journals.lww.com/ecdt/fulltext/2019/68040/serum_levels_of_vitamin_d,_magnesium,_and_calcium.12.aspx|3].
*__Berberine__: Limited evidence in asthma; focuses on metabolic and antimicrobial benefits [https://www.buzzrx.com/blog/what-are-berberine-benefits-and-drawbacks|21].
*__Zinc, Omega-3, Sulforaphane__: Absent from the provided studies in an asthma context, though theoretical immune benefits exist.
__~~#00F:Conclusion: Prioritizing Supplements for Asthma Management~~__
Based on current evidence:
#__Resveratrol__ emerges as the most promising due to its dual anti-inflammatory and VDR-synergistic effects, particularly in steroid-resistant asthma.
#__Quercetin__ offers acute symptom relief and long-term immune modulation, making it ideal for exacerbation management.
#__Curcumin__ provides robust anti-remodeling effects, though further research is needed to clarify its VDR-specific mechanisms.
__Clinical Implications__: Combining these supplements with Vitamin D supplementation may optimize outcomes, especially in deficient populations. Future trials should explore dose-response relationships and synergistic formulations.
__~~#00F:Future Directions~~__
*__Personalized Medicine__: Genetic screening for VDR polymorphisms could identify patients most likely to benefit from supplementation [https://pubmed.ncbi.nlm.nih.gov/15282199/|5] [https://www.spandidos-publications.com/10.3892/etm.2018.6867|14].
*__Combination Therapies__: Investigating Resveratrol + Vitamin D or Quercetin + corticosteroids may enhance efficacy while minimizing steroid doses.
*__Long-Term Safety__: Despite promising data, prolonged use of high-dose supplements requires rigorous safety assessments.
This analysis underscores the potential of natural compounds to complement conventional asthma therapies, offering a paradigm shift toward integrative
---
!!!!VitaminDWiki – ((Overview Asthma and Vitamin D))  contains
{include page=&quot;Overview Asthma and Vitamin D&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;}
---
!!!!VitaminDWiki - The risk of ~~#F00:50+ ~~ diseases at least double with poor ((Vitamin D Receptor))
---
!!!!A poor VDR increases the risk of Asthma (but not the opposite assocation) - Feb 2025
What is the direction of the association between the Vitamin D receptor and Asthma? Does a poor VDR increase the risk of Asthma or does Asthma reduce the activation of the VDR?
__[https://www.perplexity.ai/search/what-is-the-direction-of-the-a-lmopy0OJROykvQnaEtYE5Q|Perplexity Deep Research]__
*((Parkinson&#39;s Disease might be treated by TENS))

</code>
</pre>
